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Objective We assessed the impact of breastfeeding by women infected with human immunodeficiency virus (HIV)-1 on their 
morbidity and risk of mortality and on the mortality of their children.
Methods We analysed longitudinal data from two previous randomized clinical trials of mother-to-child transmission of HIV 
conducted between April 2000 and March 2003 in the Republic of Malawi, Africa. Mothers infected with HIV, and their newborns, 
were enrolled at the time of their child’s birth; they then returned for follow-up visits when the child was aged 1 week, 6–8 weeks 
and then 3, 6, 9, 15, 18, 21 and 24 months. Patterns of breastfeeding (classified as exclusive, mixed or no breastfeeding), maternal 
morbidity and mortality, and mortality among their children were assessed at each visit. Descriptive and multivariate analyses were 
performed to determine the association between breastfeeding and maternal and infant outcomes.
Findings A total of 2000 women infected with HIV were enrolled in the original studies. During the 2 years after birth, 44 (2.2%) 
mothers and 310 (15.5%) children died. (Multiple births were excluded.) The median duration of breastfeeding was 18 months 
(interquartile range (IQR) = 9.0–22.5), exclusive breastfeeding 2 months (IQR = 2–3) and mixed feeding 12 months (IQR = 6–18). 
Breastfeeding patterns were not significantly associated with maternal mortality or morbidity after adjusting for maternal viral load 
and other covariates. Breastfeeding was associated with reduced mortality among infants and children: the adjusted hazard ratio 
for overall breastfeeding was 0.44 (95% confidence interval (CI) = 0.28–0.70), for mixed feeding 0.45 (95% CI = 0.28–0.71) and 
for exclusive breastfeeding 0.40 (95% CI = 0.22–0.72). These protective effects were seen both in infants who were infected with 
HIV and those who were not.
Conclusion Breastfeeding by women infected with HIV was not associated with mortality or morbidity; it was associated with highly 
significant reductions in mortality among their children.
Bulletin of the World Health Organization 2006;84:546-554.
Voir page 552 le résumé en français. En la página 553 figura un resumen en español.
Introduction
In sub-Saharan Africa, women infected 
with human immunondeficiency virus 
(HIV)-1 continue to breastfeed their 
infants for several reasons. Breastfeed-
ing satisfies the nutritional needs of 
an infant and is frequently encouraged 
by other family members as a cultural 
norm. Women who do not initiate and 
maintain breastfeeding raise suspicion in 
the community about their HIV status, 
and this may lead to discrimination. 
Furthermore, substitutes for breast milk 
are either expensive or not safe to use 
owing to a lack of safe water, and con-
tainers for feeding the infant are easily 
contaminated.1 Breastfeeding protects 
the infant against diarrhoeal and upper 
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respiratory diseases, and has many other 
well documented biological benefits.2–6
However, breastfeeding is the most 
important route of postnatal HIV trans-
mission to the infant.7 To counterbalance 
the benefits and risks of breastfeeding 
when the mother is infected with HIV, 
WHO, UNICEF and others have devel-
oped guidelines to assist women in mak-
ing an informed decision about whether 
to breastfeed.8 In settings where formula 
feeding is not affordable, it is generally 
recognized that women infected with 
HIV should continue to exclusively 
breastfeed their infants until they are 
aged 6 months and then abruptly wean 
them. The adverse effect of breastfeeding 
on the health of mothers has appeared 
minimal in settings where HIV is not 
a major problem.9 However, the im-
pact of breastfeeding on the health of 
women infected with HIV is not well 
understood.
Several studies from sub-Saharan 
Africa have reported the effects of 
breastfeeding on the health of mothers. 
A randomized trial conducted in Kenya 
compared breastfeeding to formula feed-
ing and reported there was an increased 
risk of maternal death among women 
who breastfed their infants.10 However, 
the number of events in this second-
ary analysis was small (24 deaths). Two 
subsequent observational studies from 
South Africa and the United Republic of 
Tanzania found no association between 
breastfeeding and maternal mortality 
among women infected with HIV.11,12 
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A randomized study in Zambia of women 
infected with HIV that compared those 
who abruptly ceased breastfeeding at 
4 months with those who engaged in 
prolonged breastfeeding reported no 
difference in mortality based on dura-
tion of breastfeeding.13 Additionally, a 
meta-analysis that used data from several 
clinical trials conducted in Africa found 
that the risk of mortality among women 
infected with HIV did not differ accord-
ing to how the child was fed.14
In this study from the Republic 
of Malawi, we examined the impact of 
breastfeeding by women infected with 
HIV-1 on both their and their children’s 
mortality and on several indicators of 
maternal morbidity.
Methods
The data for the present analysis were 
originally obtained as part of two clini-
cal trials (the Nevirapine/AZT (NVAZ) 
Studies) seeking to prevent mother-to-
child transmission of HIV through the 
use of short-course antiretroviral post-
exposure prophylaxis given immediately 
after birth.15,16 Women were enrolled in 
the NVAZ studies based on their time of 
presentation for delivery. The HIV status 
of these women was not known on their 
arrival at the participating health centres. 
After obtaining informed consent for 
HIV counselling and testing, and after 
being enrolled in these trials, women 
who presented early (with an approxi-
mate time of  4 hours from arrival to 
delivery, known as early presenters) were 
provided with a single dose of nevirapine 
intrapartum if they were found to be 
infected with HIV. The babies of early 
presenters were randomized to receive 
orally either a standard single dose of 
nevirapine only or the same dose of ne-
virapine plus zidovudine twice daily for 
1 week. Women who presented late (with 
an approximate time < 4 hours from ar-
rival to delivery, known as late presenters) 
did not receive intrapartum nevirapine 
because the time was not adequate to 
conduct counselling and HIV testing 
prior to delivery. These women were 
counselled and tested postnatally, and if 
they were infected with HIV, their babies 
were randomized to receive orally either 
a standard single dose of nevirapine only 
or nevirapine plus zidovudine — that is, 
the same regimen as the babies born to 
early presenters. Dosing with the drugs 
started as soon as the infant could swal-
low fluids. Only singleton births were 
included in the NVAZ studies.
Following delivery, the women and 
their infants were seen at 1 week and 6–8 
weeks and then at 3, 6, 9, 12, 15, 18, 21 
and 24 months. At delivery, sociodemo-
graphic information and the obstetric 
and medical history were obtained. At 
each subsequent visit, case-report forms 
were completed to document the health 
status and survival of the mother and her 
child (including documentation of in-
tercurrent illnesses based on the history 
and physical examination). Additionally, 
a detailed questionnaire was completed 
at each visit to describe breastfeeding pat-
terns since the last visit.
Blood samples were collected from 
the mother at enrolment to measure 
baseline viral load and haemoglobin 
levels. Samples of the infant’s blood were 
collected at birth and at the 6–8 week 
visit to determine the child’s HIV status 
(details of sample collection, testing 
procedures and interpretation of results 
are described elsewhere).15,16 Maternal 
plasma viral load was tested using Roche 
Diagnostics Amplicor HIV-1 Monitor 
test, version 1.5 (Indianapolis (IN), 
USA), and infant dried blood spots were 
tested for HIV RNA using NucliSens 
HIV-1 QL (bioMérieux, Durham (NC), 
USA). These tests were performed in the 
United States at a central laboratory at 
the University of North Carolina, Chapel 
Hill (NC).
The main outcomes of interest in 
this study were maternal mortality and 
morbidity, and infant and child mortal-
ity during the first 2 years after birth. 
Deaths of mothers and their children 
were ascertained through questionnaires 
and by actively tracing infant–mother 
pairs when visits were missed. Informa-
tion on the reported date and cause 
of death was ascertained to the extent 
possible. In Malawi most deaths occur 
at home, and when the death occurs in 
hospital, postmortem examinations are 
not done to establish the cause of death.
Maternal morbidity was based on 
the assessment of three health indicators. 
The first indicator was hospitalization 
and the use of any medicines as reported 
by the women at each visit. The second 
was HIV disease status as determined us-
ing the US Centers for Disease Control 
and Prevention classification. This cre-
ated two groups of women: symptomatic 
(classes 2–4) and asymptomatic (class 1); 
participants were classified based on their 
history between visits and examination 
at each visit.17 The third indicator was 
whether the woman was able to perform 
her routine activities or whether she 
required assistance from her family, as 
reported at each visit.
The main exposure variable was 
breastfeeding at each visit (as assessed 
from the interval immediately preced-
ing the visit). The first variable was the 
status of any breastfeeding taking place; 
this was reported as a “yes” or “no” and 
was used as an overall assessment of the 
status of breastfeeding at each visit. The 
second variable was the frequency of 
breastfeeding. Women were categorized 
into two groups: those who breastfed 
 5 times during the day and night or 
< 5 times during day and night. The third 
variable was the mode of breastfeeding. 
Breastfeeding was described as “exclu-
sive” when nothing other than breast 
milk was given by mouth (excluding 
oral medications). Feeding was described 
as “mixed” when other liquid and solid 
foods were added. It was described as “no 
breastfeeding” when breastfeeding was 
not started at all or when breastfeeding 
stopped at any age. The purpose of these 
different definitions of breastfeeding 
patterns was to check for consistency 
between associations and also to assess 
whether intensity of breastfeeding (that 
is, exclusive breastfeeding is considered 
to be more intense than mixed because 
it requires more maternal energy) and 
assumed quantity of breastfeeding (es-
timated by frequency) increases the 
risk of maternal mortality or morbidity 
or conversely whether the intensity of 
breastfeeding protects infants against 
death.
Descriptive analyses of breastfeed-
ing and other factors were conducted, 
and Kaplan–Meier survival analyses were 
used to estimate cumulative maternal 
and child mortality. To assess the associa-
tion of maternal and child mortality with 
breastfeeding we used Cox proportional 
hazards survival analyses. We used Gen-
eralized Estimating Equations (GEE) 
logit-link models to assess the associa-
tion between various maternal morbidity 
factors (measured at multiple visits for 
each woman) and breastfeeding to ac-
count for correlation between repeated 
visits and these repeated observations.18 
In both types of analyses, univariate and 
multivariate estimates (hazard ratios 
(HR) from Cox models and odds ratios 
from GEE logit-link models) and 95% 
confidence intervals (CI) were obtained. 
These analyses were stratified into shorter 
time periods of 6 months and 12 months 
because breastfeeding patterns change 
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over time (for example, women start 
by exclusively breastfeeding, change 
to mixed feeding and ultimately stop 
breastfeeding). We also repeated the GEE 
analyses and included the number of 
months since delivery in these models 
to act as an indicator variable account-
ing for the likelihood that women may 
become more sick at later visits as their 
HIV infection progresses with advanc-
ing age. In other words, women whose 
disease is advanced might have less time 
to breastfeed their babies as the study 
progressed. This could confound the 
interpretation of these associations and 
the direction of causality may not be 
clear.14
In the multivariate models we 
separately included each breastfeeding 
pattern as a time-dependent variable to 
assess the direction and magnitude of 
the association with maternal mortal-
ity or morbidity after simultaneously 
adjusting for the same set of covariates: 
maternal age (< 25 years versus  25 
years), viral load and haemoglobin level 
at enrolment (continuous variables), and 
nutritional status/wasting at each visit, 
which was based on an estimate of the 
mother’s body mass index (BMI; a con-
tinuous variable). To account for any 
underlying socioeconomic differences 
in the models that involved mortality 
among the children, we adjusted for 
the antiretroviral prophylaxis the infant 
received at birth and time of presentation 
of the mother (early versus late). We also 
stratified these models by the infant’s 
HIV status to determine the impact of 
breastfeeding patterns both on children 
infected with HIV and those who were 
uninfected, after simultaneously adjust-
ing for other risk factors. SAS statistical 
software (Cary, NC, USA), version 8.2, 
was used to conduct these analyses.
The NVAZ study was approved 
in Malawi by the Research and Ethics 
Committee at the University of Malawi 
College of Medicine and in the United 
States by the Committee on Human 
Research at the Johns Hopkins Bloom-
berg School of Public Health. All women 
gave written informed consent for HIV 
testing and enrolment. Women and chil-
dren received free routine clinical care. 
Referral for antiretroviral treatment for 
eligible participants is available as part 
of the programme of the Global Fund 
to fight AIDS, Tuberculosis and Malaria 
in Malawi.
Findings
A total of 2000 women were enrolled 
in the two NVAZ randomized clinical 
trials; 889 (44.5%) were early presenters 
and 1111 (55.5%) were late presenters. 
The mean maternal age was 24.9 years 
(median = 24.0 years); mean parity was 
3.0 children; 220 women (11%) had 
had no education; 1260 (63%) had at-
tended primary school; and 520 (26%) 
had had more than a primary-school 
education. Of the 2000 women enrolled 
in this study, 1838 (91.9%) returned for 
any postnatal follow-up visit; and it was 
known for 9 of the mothers who did 
not return (0.4%) that their child had 
died. Therefore, 153 (7.7%) women 
were lost to follow-up and did not con-
tribute follow-up data to this analysis. 
The sociodemographic and biological 
characteristics of the 1838 women who 
returned and 162 (153 + 9) women who 
did not return for follow-up were com-
parable, including in terms of baseline 
maternal viral load.
Overall, 44 (2.2%) of the 2000 
women and 310 (15.5%) of their chil-
dren died. Cumulative maternal mortal-
ity at 12 months based on Kaplan–Meier 
analysis was 18/1000; and at 24 months 
it was 32/1000. The reported causes of 
death among the 44 mothers who died 
were tuberculosis (21%), pneumonia 
(18%), malaria (16%), diarrhoea (14%), 
herpes zoster or Kaposi’s sarcoma or men-
ingitis (7%), and other diseases (9%); the 
cause of death was unknown for 18% of 
women. Among children, the cumulative 
mortality based on the Kaplan–Meier 
analysis at 12 months was 132/1000, 
and at 24 months was 195/1000. Among 
children infected with HIV mortality 
was significantly higher compared with 
mortality among children who were not 
infected: mortality was approximately 
tenfold higher at 12 months (45/1000 
versus 457/1000, P < 0.0001, Log–Rank 
test) and approximately sevenfold higher 
Table 1.  Hazard ratios for risk factors associated with death of women infected with HIV, Malawi, 2000–03 (Cox proportional 
hazards models)
Maternal characteristics Univariate Multivariate hazard ratio
   
hazard ratio
 Model 1a Model 2b Model 3c
Breastfeeding
Status 0.31  (0.10–0.96)d,e 0.35 (0.12–1.03) – –
Frequency 1.83  (0.91–3.69) – 1.66 (0.81–3.40) –
Type
 Mixed feeding versus no breastfeeding 0.28  (0.09–0.91)f – – 0.31  (0.10–0.96)e
 Exclusive versus no breastfeeding 0.79  (0.17–3.82) – – 0.97  (0.21–4.55)
Age (< 25 years versus  25 years) 0.63  (0.31–1.26) 0.71 (0.35–1.46) 0.70 (0.34–1.43) 0.68  (0.33–1.39)
Maternal viral load (Log10) g 5.34  (2.94–9.70) 3.84 (2.06–7.16) 3.89 (2.10–7.22) 3.82  (2.05–7.14)
Maternal haemoglobin g  0.76  (0.66–0.88) 0.80 (0.68–0.93) 0.79 (0.68–0.93) 0.79  (0.68–0.92)
BMI h 0.82  (0.73–0.92) 0.87 (0.75–1.00) 0.86 (0.74–1.00) 0.87  (0.75–1.00)
a  Adjusted for breastfeeding status at each visit (yes versus no).
b  Adjusted for breastfeeding frequency at each visit ( 5 times during the day and night versus < 5 times).
c  Adjusted for type (mode) of breastfeeding at each visit, comparing mixed feeding or exclusive breastfeeding versus no breastfeeding. 
d  Values in parentheses are 95% confidence intervals.
e  P = 0.04.
f  P = 0.03.
g  Maternal viral load and haemoglobin as continuous variables measured at baseline.
h  BMI = body mass index (weight (kg)/height (metres)²); used as a continuous variable to indicate nutritional status/wasting at each visit.
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at 24 months (83/1000 versus 639/1000, 
P < 0.0001, Log–Rank test). The re-
ported causes of death were respiratory 
infections (33%), gastroenteritis (16%), 
septicaemia (11%), malnutrition (8%), 
malaria (8%), meningitis (5%), other 
diseases (4%), and unknown (15%).
At the postnatal visits at 1 week 
1831/1838 (99.6%) of women who 
returned for follow-up were still breast-
feeding; at 6 weeks the number was 1827 
(99.4%). The mean duration of breast-
feeding was 15.4 months (median = 
18 months; interquartile range (IQR) = 
9.0–22.5 months). Women exclusively 
breastfed their infants for a mean of 2.4 
months (median = 2 months; IQR = 2–3 
months), and practised mixed feeding 
for a mean of 11.7 months (median = 12 
months; IQR = 6–18 months). Because 
breastfeeding is the main factor of inter-
est in this study and women may opt to 
breastfeed or not breastfeed based on their 
health, we compared the characteristics of 
women who were breastfeeding to those 
who were not at various time points. At 
3 months, 6 months and 12 months 
after birth there were no differences in 
important characteristics, such as base-
line maternal viral load and haemoglobin 
and BMI at each visit among women 
who breastfed (exclusively or engaged 
in mixed feeding) or did not breastfeed. 
However, the number of women who 
did not breastfeed at all time points was 
small (for example, only 50 women were 
not breastfeeding at 12 months).
To minimize bias, mothers’ data 
were censored if their children died first. 
In the univariate and multivariate analy-
ses used to assess the association between 
breastfeeding and maternal mortality and 
morbidity, data from 11 women were 
censored at the time of their infant’s 
death. In the univariate analysis all pat-
terns of breastfeeding (overall status, fre-
quency and mode) at each visit were not 
significantly associated with increased risk 
of maternal death (Table 1). Controlling 
for maternal age, viral load, haemoglobin 
and BMI did not change these findings 
(Table 1). Higher maternal viral load 
was strongly and consistently associated 
with higher risk of maternal death; the 
risk of maternal death was threefold 
greater for each 1 log10 unit in each of the 
three multivariate models that included 
breastfeeding status, frequency or type. 
In adjusted models, higher maternal 
haemoglobin level at enrolment and BMI 
values at each visit were significantly as-
sociated with maternal survival (that is, 
they were protective).
Table 2.  Odds ratios for the association between breastfeeding and maternal morbidity in women infected with HIV, Malawi, 
2000–03 (Generalized Estimating Equations (GEE) models)a 
Variables Univariate Multivariate analysis
     
analysisb
 Model 1c Model 2d Model 3e
Hospitalization and use of medicines
Breastfeeding
 Status 0.94 (0.77–1.14) 0.91 (0.73–1.13) – –
 Frequency 0.99 (0.87–1.13) – 0.97 (0.85–1.12) –
 Type    
  Mixed feeding versus no breastfeeding 1.05 (0.86–1.29) – – 0.99 (0.79–1.24)
  Exclusive versus no breastfeeding 0.74 (0.60–0.92) f – – 0.76 (0.60–0.96) g
Maternal HIV disease status 
(symptomatic versus not symptomatic) 
Breastfeeding
 Status 0.93 (0.75–1.15) 0.89 (0.69–1.14) – –
 Frequency 1.01 (0.88–1.15) – 0.97 (0.84–1.13) –
 Type    
  Mixed feeding versus no breastfeeding 0.93 (0.75–1.16) – – 0.87 (0.68–1.12)
  Exclusive versus no breastfeeding 0.93 (0.73–1.17) – – 0.92 (0.70–1.21)
Limitation of maternal physical 
activities 
Breastfeeding
 Status 0.77 (0.59–1.00) 0.70 (0.53–0.93) – –
 Frequency 1.03 (0.86–1.25) – 0.99 (0.81–1.22) –
 Type    
  Mixed feeding versus no breastfeeding 0.76 (0.57–0.99) – – 0.67 (0.49–0.90)
  Exclusive versus no breastfeeding 0.79 (0.59–1.05) – – 0.77 (0.56–1.05)
a  The outcome in each of these GEE models was maternal morbidity based on reported maternal hospitalization and use of medicines, maternal HIV disease status and 
limitations of physical activity. See Methods for definitions. Other variables adjusted for in these models in addition to breastfeeding were age, baseline maternal 
viral load and haemoglobin, and body mass index (weight (kg)/height (metres)²), which was used as an indicator of nutritional status/wasting, at each visit (see 
Table 3). 
b  Values are odds ratios (95% confidence intervals).
c  Adjusted for breastfeeding status at each visit (yes versus no).
d  Adjusted for breastfeeding frequency at each visit ( 5 times during the day and night versus < 5 times).
e  Adjusted for type (mode) of breastfeeding at each visit by comparing mixed feeding or exclusive breastfeeding versus no breastfeeding.
f  P = 0.008.
g  P = 0.02.
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Table 3.  Odds ratios for risk factors associated with maternal morbidity in women infected with HIV, Malawi, 2000–03 
(Generalized Estimated Equations (GEE) models)
Variables  Univariate analysisa  Multivariate analysis
  Model 1b Model 2c Model 3d
Hospitalization and use of medicines
Age (< 25 years versus  25 years) 0.69 (0.58–0.81) 0.64 (0.54–0.76) 0.67 (0.56–0.81) 0.64 (0.54–0.77)
Maternal viral load (Log10) e 1.29 (1.15–1.45) 1.24 (1.09–1.39) 1.23 (1.08–1.39) 1.24 (1.10–1.40)
Maternal haemoglobine 0.95 (0.91–0.99) 0.97 (0.93–1.01) 0.98 (0.94–1.02) 0.97 (0.92–1.01)
BMI f 0.92 (0.89–0.95) 0.93 (0.90–0.96) 0.95 (0.92–0.99) 0.94 (0.91–0.97)
Maternal HIV disease status  
(symptomatic versus not symptomatic)
Age (< 25 years versus  25 years) 0.67 (0.56–0.80) 0.63 (0.52–0.75) 0.66 (0.55–0.80) 0.63 (0.52–0.75)
Maternal viral load (Log10) e 1.83 (1.61–2.07) 1.64 (1.44–1.86) 1.61 (1.41–1.84) 1.63 (1.44–1.86)
Maternal haemoglobin e 0.93 (0.89–0.97) 0.96 (0.91–1.01) 0.97 (0.93–1.02) 0.96 (0.91–1.00)
BMI f 0.87 (0.84–0.90) 0.89 (0.86–0.92) 0.90 (0.87–0.94) 0.89 (0.86–0.92)
Limitation of maternal physical activities 
Age (< 25 years versus  25 years) 0.70 (0.57–0.86) 0.63 (0.50–0.78) 0.66 (0.52–0.83) 0.63 (0.50–0.78)
Maternal viral load (Log10) e 1.66 (1.41–1.94) 1.50 (1.28–1.77) 1.51 (1.28–1.80) 1.49 (1.27–1.76)
Maternal haemoglobine 0.92 (0.87–0.98) 0.95 (0.90–1.01) 0.97 (0.91–1.03) 0.95 (0.90–1.01)
BMI f 0.88 (0.84–0.92) 0.88 (0.84–0.93) 0.90 (0.85–0.95) 0.88 (0.84–0.93)
a  Values are odds ratios (95% confidence intervals).
b  Adjusted for breastfeeding status at each visit (yes versus no).
c  Adjusted for breastfeeding frequency at each visit ( 5 times during the day and night versus < 5 times).
d  Adjusted for type (mode) of breastfeeding at each visit by comparing mixed feeding or exclusive breastfeeding versus no breastfeeding.
e  Maternal viral load and haemoglobin as continuous variables measured at baseline.
f  BMI = body mass index (weight (kg)/height (metres)²); used as a continuous variable to indicate nutritional status/wasting at each visit.
Similar to the findings above, breast-
feeding (yes/no, frequency or type) was 
not associated with an increased risk 
of maternal morbidity as assessed by 
hospitalization and use of medicines, 
symptomatic HIV disease or limitations 
on physical activities (Table 2). Con-
trolling for maternal age, viral load, 
haemoglobin level and BMI did not 
change these findings (Table 3). In all 
these models, higher maternal viral load 
was significantly associated with higher 
odds of maternal morbidity while higher 
maternal baseline haemoglobin and BMI 
at each visit were associated with lower 
odds of morbidity (that is, they had a 
protective effect). Younger maternal age 
(< 25 years) was also significantly associ-
ated with lower odds for all morbidity 
indicators assessed in these models after 
adjusting for other variables.
At each visit, both the status and 
type of breastfeeding by women infected 
with HIV were significantly associated 
with a 55–60% decreased risk of child 
mortality: adjusted HR = 0.44 (95% 
CI = 0.28–0.70) for overall status of 
feeding; 0.45 (95% CI = 0.28–0.71) 
for mixed feeding; and 0.40 (95% CI = 
0.22–0.72) for exclusive breastfeeding 
(Table 4). Higher maternal viral load at 
enrolment was significantly associated 
with increased child mortality in all 
models; the risk of child mortality was 
increased by more than twofold for 
each log 10 unit. Both a higher maternal 
haemoglobin level at enrolment and 
higher values of BMI at each visit were 
also associated with improved survival 
for children. Maternal age, presentation 
at time of delivery (early versus late) and 
prophylaxis with short-course antiretro-
viral treatment were not associated with 
risk of child mortality after adjusting for 
other variables. Limiting this analysis 
to only deaths among infants (that is, 
among children aged  12 months) did 
not change these results: breastfeeding 
status and type (mixed or exclusive) 
remained highly significantly protective. 
For breastfeeding status the adjusted HR 
for infant death was 0.31 (95% CI = 
0.16–0.59). For mixed feeding versus no 
breastfeeding, the adjusted HR for infant 
death was 0.31 (95% CI = 0.16–0.61). 
For exclusive feeding versus no breast-
feeding the adjusted HR was 0.29 (95% 
CI = 0.14–0.59). The HIV-free survival 
estimate at 12 months was 79.8% and 
at 24 months was 72.8%.
Stratifying the models in Table 4 
by the infection status of the infant at 
6–8 weeks showed there was a signifi-
cantly lower risk of death if the child 
was breastfed both for children who 
were infected with HIV and those who 
were not infected, after controlling for 
the same variables. Among children 
who were not infected with HIV, the 
adjusted HR for reported overall breast-
feeding (status) was 0.34 (95% CI = 
0.18–0.64); for exclusive breastfeeding 
it was 0.11 (95% CI = 0.04–0.32); and 
for mixed feeding it was 0.37 (95% CI = 
0.20–0.69). Among children infected 
with HIV the adjusted HR for reported 
overall breastfeeding was 0.36 (95% CI = 
0.19–0.71); for exclusive breastfeeding 
it was 0.43 (95% CI = 0.20–0.93); and 
for mixed feeding it was 0.35 (95% CI = 
0.18–0.61). As in the analysis not strati-
fied by HIV status (Table 4), maternal 
viral load was strongly associated with 
increased risk of death both for children 
who were infected with HIV and for 
those who were not, but frequency of 
breastfeeding was not associated with 
mortality.
Discussion
In urban Malawi, the prevalence of 
HIV-1 is approximately 30% among 
women attending antenatal clinics,19 
and breastfeeding is almost universal.15,16 
National estimates show that levels of 
551Bulletin of the World Health Organization | July 2006, 84 (7)
Research
Taha E Taha et al. Breastfeeding and the health of HIV-positive mothers
Table 4.  Hazard ratios for risk factors associated with mortality among children born to women infected with HIV, Malawi, 
2000–03 (Cox proportional hazards model)
Variables  Univariate  Multivariate analysis
  
analysisa
 Model 1b Model 2c Model 3d
Breastfeeding
Status 0.42 (0.27–0.66) 0.44 (0.28–0.70) – –
Frequency 1.20 (0.95–1.52) – 1.24 (0.96–1.59) –
Type    
 Mixed feeding versus no breastfeeding 0.42 (0.27–0.66) – – 0.45 (0.28–0.71)
 Exclusive versus no breastfeeding 0.43 (0.25–0.76) – – 0.40 (0.22–0.72)
Age (< 25 years versus  25 years) 1.06 (0.84–1.32) 1.10 (0.86–1.42) 1.08 (0.84–1.39) 1.11 (0.86–1.43)
Maternal viral load (Log10) e  2.69 (2.26–3.20) 2.56 (2.10–3.13) 2.59 (2.12–3.16) 2.56 (2.10–3.13)
Maternal haemoglobine 0.93 (0.88–0.98) 0.97 (0.92–1.03) 0.97 (0.92–1.03) 0.97 (0.92–1.03)
BMI f 0.89 (0.85–0.93) 0.94 (0.89–0.98) 0.94 (0.89–0.98) 0.94 (0.89–0.98)
Presentation (early versus late) g 0.69 (0.55–0.87) 0.96 (0.75–1.24) 0.84 (0.65–1.10) 0.84 (0.64–1.09)
Treatment (nevirapine + zidovudine 0.98 (0.78–1.22) 0.84 (0.64–1.09) 0.94 (0.73–1.21) 0.96 (0.75–1.24) 
versus nevirapine only)
a  Values are hazard ratios (95% confidence intervals).
b  Adjusted for breastfeeding status at each visit (yes versus no). 
c  Adjusted for breastfeeding frequency at each visit ( 5 times during the day and night versus < 5 times).
d  Adjusted for type (mode) of breastfeeding at each visit by comparing mixed feeding or exclusive breastfeeding versus no breastfeeding.
e  Maternal viral load and haemoglobin as continuous variables measured at baseline.
f  BMI = body mass index (weight (kg)/height (metres)²); used as a continuous variable to indicate nutritional status/wasting at each visit.
g  See text for full description of presentation and treatment variables.
maternal and child mortality are high in 
Malawi: in 2000 the maternal mortality 
ratio was 1120/100 000 live births and 
mortality among children younger than 
5 years was 188.6/1000 live births.20 The 
current analysis showed that breastfeed-
ing is not associated with an increased 
risk of maternal mortality or morbidity. 
A lack of association with maternal 
mortality was observed with all the mea-
sures we used to assess breastfeeding: 
overall (status), type and frequency. For 
example, we used type of feeding to ap-
proximate the intensity of this practice, 
assuming that exclusive breastfeeding 
will likely require more maternal energy 
than mixed feeding.21 Our results appear 
to support this argument: mixed feeding 
was associated with a significantly lower 
risk of death (HR = 0.31, 95% CI = 
0.10–0.96) while exclusive breastfeed-
ing was not (Table 1). As discussed by 
others,14 the protective effect of exclusive 
breastfeeding (as shown in Table 2) is 
most likely the result of the fact that 
healthier mothers opt to breastfeed ex-
clusively while sicker mothers do not 
breastfeed. The lack of an association 
between breastfeeding and maternal 
mortality in our study is also in agree-
ment with the results of studies from the 
United Republic of Tanzania and South 
Africa.11,12
Breastfeeding was also not associ-
ated with morbidity indicators, such 
as maternal hospitalization or use of 
medicines, symptomatic HIV disease, 
or limitations of physical activity. These 
results suggest that breastfeeding does 
not lead to faster disease progression, 
advanced HIV disease and, ultimately, 
death from AIDS. This corroborates 
the results of the study from the United 
Republic of Tanzania.12 Similar to the 
mortality findings, the most important 
maternal factor that increased the risk 
of morbidity in all the outcomes we 
examined was higher maternal viral load 
(Table 3). As expected, women with 
higher haemoglobin and BMI (that is, 
the healthier women) had significantly 
reduced morbidity and mortality in all 
the models. Young age (< 25 years) also 
appeared protective in all analyses of 
maternal morbidity, possibly because 
compared with older women, younger 
women have better overall health. There 
also could be differences between younger 
and older women in factors that we did 
not assess (for example, nutritional and 
immunological reserves).
Another important finding of this 
study is that breastfeeding by mothers 
infected with HIV is associated with a 
significantly lower risk of mortality for 
infants and children (Table 4). Breast-
feeding was protective against mortality 
among infants and children regardless 
of whether the infant was infected 
with HIV. Mixed feeding (versus not 
breastfeeding) was also associated with 
substantial reductions in mortality in 
each of the infants regardless of their 
HIV status (a reduction of approxi-
mately 60%). These findings differ from 
a meta-analysis that included data from 
several African countries and reported 
no association between infant mortality 
and either ever breastfeeding or never 
breastfeeding.22 These differences could 
be due to variability in breastfeeding 
measurements (ever breastfeeding versus 
never breastfeeding in the multicountry 
study) between the two studies and 
variability in infant mortality among 
countries. As in the analyses of maternal 
morbidity and mortality, maternal viral 
load was significantly associated with 
increased child mortality, and higher 
maternal haemoglobin and BMI were 
significantly associated with lower child 
mortality.
This study has some limitations. 
We tried to obtain in-depth information 
about breastfeeding patterns, but infor-
mation and misclassification biases may 
have occurred. For example, the reported 
frequency of breastfeeding was crude, 
and the cut-off we used (5 times during 
the day and night) was arbitrary. Like-
wise, there is no certainty that reported 
exclusive breastfeeding is completely 
limited to breast milk, and complemen-
tary feeds might occasionally have been 
given. This study was not a randomized 
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trial of breastfeeding and formula feed-
ing, and changes in breastfeeding as HIV 
disease progressed could have introduced 
bias. We compared the characteristics of 
women who breastfed (exclusively or en-
gaged in mixed feeding) and those who 
did not breastfeed at various times dur-
ing follow-up: there were no significant 
differences in either sociodemographic 
or biological factors (such as baseline 
viral load, haemoglobin or BMI). Loss 
to follow up from the outset was not 
substantial; however, the high rates of 
child mortality and subsequent censor-
ing of mothers may have contributed to 
some potential biases. There were no dif-
ferences in the characteristics of women 
who were lost to follow up and those 
who returned. The effect of these biases 
will likely be non-differential.
Conclusion
This study has important policy implica-
tions, and confirms findings from other 
studies in Africa. Breastfeeding pat-
terns were not associated with maternal 
mortality or morbidity, and did not 
increase HIV disease progression in this 
group of women. It is reassuring that 
breastfeeding by women infected with 
HIV was not a risk to them and in fact 
was highly protective against mortality 
among their infants irrespective of the 
child’s initial HIV infection status. It 
is also in line with the general recom-
mendations adopted in Malawi and 
several other countries where breast milk 
substitutes are not available. It appears 
that the important immunological and 
antipathogenic factors in breast milk 
that provide protection for the child 
against several childhood diseases are 
well maintained even if the mother is 
infected with HIV.23 However, the fact 
that the baby may become infected 
through breastfeeding and, ultimately, 
the higher risk of death associated with 
HIV infection as demonstrated in this 
study should always be acknowledged. 
The major risk factor associated with 
mortality for both mothers and their 
children is AIDS itself (the level of 
plasma HIV load).24 Therefore, provid-
ing antiretroviral treatment to mothers 
(and their children) should be a major 
priority in order to save lives.  O
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Résumé
L’influence  de l’allaitement au sein sur la santé des mères positives pour le VIH et sur celle de leurs  
enfants en Afrique subsaharienne
Objectif Nous avons évalué l’influence de l’allaitement au sein 
sur la morbidité et le risque de mortalité des mères porteuses 
du virus de l’immunodéficience humaine (VIH-1) ainsi que sur la 
mortalité de leurs enfants.
Méthodes Nous avons étudié les données longitudinales tirées 
de deux essais cliniques randomisés portant sur la transmission 
du VIH de la mère à l’enfant qui avaient été effectués entre 
avril 2000 et mars 2003 en République du Malawi (Afrique). Le 
recrutement des mères porteuses du VIH et de leurs nouveau-nés 
a été effectué lors de la naissance de leur enfant ; on les a ensuite 
revues pour des visites de suivi lorsque leur enfant a atteint l’âge 
de 1 semaine, 6-8 semaines puis 3, 6, 9,15, 18, 21 et 24 mois. 
A chaque fois, le mode d’allaitement (au sein exclusivement, 
mixte ou pas d’allaitement au sein), la morbidité et la mortalité 
maternelle ainsi que la mortalité des enfants ont été notés. On a 
procédé à des analyses descriptives et à des analyses à variables 
multivariées pour déterminer l’association entre l’allaitement au 
sein et l’état de santé de la mère et de l’enfant.
Résultats Au total, 2000 femmes contaminées par le VIH ont 
été recrutées pour les études initiales.  Au cours des deux années 
suivant la naissance, 44 mères (2,2 %) et 310 enfants (15,5 %) 
sont décédés. (on n’a pas pris en compte les naissances multiples). 
La durée médiane de l’allaitement était de 18 mois (intervalle 
interquartile (IQR) = 9,0 -22,5); celle de l’allaitement exclusivement 
au sein de 2 mois (IQR = 2-3) et celle de l’allaitement mixte de 
12 mois (IQR = 6-18). On n’a pas relevé d’association significative 
entre le mode d’allaitement et la morbidité ou la mortalité 
maternelle après correction pour tenir compte de la charge virale 
maternelle et des autres covariables. Chez les nourrissons et 
les enfants plus âgés, l’allaitement au sein était associé à une 
réduction de la mortalité : le rapport des risques ajusté pour 
l’allaitement au sein en général était égal à 0,44 (intervalle de 
confiance à 95 % : 0,28 - 0,70) ; il était de 0,45 pour l’allaitement 
mixte (IC à 95 % : 0,28 - 0,71) et de 0,40 pour l’allaitement 
exclusivement au sein (IC à 95 % : 0,22 - 0,72). Ces effets 
protecteurs ont été observés chez les enfants infectés par le VIH 
comme chez ceux qui ne l’étaient pas.
Conclusion Chez les femmes infectées par le VIH, il n’y avait 
aucune association entre l’allaitement au sein et la morbidité ou 
la mortalité. Chez leurs enfants en revanche, il était associé à une 
réduction très significative de la mortalité.
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Resumen
Impacto de la lactancia materna en la salud de las madres VIH-positivas y en sus hijos en el África 
subsahariana
Objetivo Evaluamos los efectos de la lactancia materna entre 
las mujeres infectadas por el virus de la inmunodeficiencia 
humana (VIH-1) en su morbilidad y su riesgo de mortalidad y en 
la mortalidad de sus hijos.
Métodos Analizamos datos longitudinales de dos ensayos 
clínicos aleatorizados previos sobre la transmisión del VIH de la 
madre al niño realizados entre abril de 2000 y marzo de 2003 en 
la República de Malawi, África. Las madres infectadas por el VIH 
y sus recién nacidos entraron a participar en el estudio al nacer 
su hijo; luego regresaban para realizar visitas de seguimiento 
cuando el niño tenía 1 semana, 6–8 semanas, y 3, 6, 9, 15, 18, 
21 y 24 meses. En cada visita se determinaba el tipo de lactancia 
materna (exclusiva, mixta, o no amamantamiento), la morbilidad y 
mortalidad maternas, y la mortalidad entre sus hijos. Se realizaron 
análisis descriptivos y multifactoriales para determinar la relación 
entre la lactancia materna y los resultados maternos e infantiles.
Resultados Un total de 2000 mujeres infectadas por el VIH 
participaron en los estudios originales. Durante los 2 años 
posteriores al nacimiento murieron 44 madres (2,2%) y 310 niños 
(15,5%). (Se excluyeron los partos múltiples.) La duración mediana 
de la lactancia materna fue de 18 meses (intervalo intercuartílico 
(II) = 9,0 - 22,5), la de la lactancia materna exclusiva, de 2 meses 
(II = 2 - 3), y la de la alimentación mixta, de 12 meses (II = 6 -18). 
El tipo de lactancia materna no influyó de forma significativa 
en la  mortalidad y la morbilidad maternas después de ajustar 
en función de la carga viral materna y de otras covariables. La 
lactancia materna se asoció a una reducción de la mortalidad 
entre los lactantes y los niños: el cociente de riesgos instantáneos 
(hazard ratio) ajustado para la lactancia materna en general fue 
de 0,44 (intervalo de confianza (IC) del 95% = 0,28 - 0,70); para 
la alimentación mixta, de 0,45 (IC95% = 0,28 - 0,71); y para la 
lactancia materna exclusiva, de 0,40 (IC95% = 0,22 - 0,72). Estos 
efectos protectores se observaron tanto entre los lactantes que 
estaban infectados por el VIH como entre los que no lo estaban.
Conclusión La lactancia materna entre las mujeres infectadas 
por el VIH no se asoció a diferencias de la mortalidad o la 
morbilidad, pero sí a una disminución muy importante de la 
mortalidad entre sus hijos.
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ملخص
تأثري اإلرضاع من الثدي عىل صحة األمهات اإليجابيات لفريوس العوز املناعي البرشي
وصحة أطفالهن يف البلدان الواقعة جنوب الصحراء األفريقية
الهدف: قيَّمنا تأثري اإلرضاع من الثدي لدى األمهات املصابات بعدوى النمط 
األول من فريوس العوز املناعي البرشي عىل معدالت املراضة لديهن وخطر 
املراضة والوفيات ولدى أطفالهن.
الطريقة: أجرينا تحلياًل طوالنياً للمعطيات املجموعة من دراستني رسيريتني 
)إكلينيكيتني( سابقتني حول رساية فريوس العوز املناعي البرشي من األمهات 
إىل أطفالهن يف الفرتة بني نيسان/أبريل 2000 وآذار/مارس 2003، يف جمهورية 
ماالوي يف أفريقيا. وقد شملت الدراسة األمهات املصابات بعدوى فريوس العوز 
املناعي البرشي منذ لحظة والدتهن، ثم استقدمن مع ولدانهن لزيارات متابعة 
عند بلوغ الوليد من عمره أسبوعاً، ثم 6 – 8 أسابيع، ثم 3 أشهر، ثم 
9 أشهر، ثم 18 شهراً، ثم 21 شهراً، ثم 24 شهراً. وقد صنفت أمناط الرضاعة 
وعدم  مختلطة،  ورضاعة  الثدي،  من  اإلرضاع  عىل  االقتصار  إىل  الثدي  من 
الرضاعة من الثدي. ويف كل زيارة كنا نقيِّم أمناط الرضاعة من الثدي، معدالت 
أجرينا  ثم  الولدان،  بني  الوفيات  معدالت  األمهات،  لدى  والوفيات  املراضة 
الرضاعة من  الرتابط بني  للتعرُّف عىل  املتغريات  تحليالت وصفية ومتعددة 
الثدي والحصائل لدى األمهات ولدى الرضع.
املوجودات: شملت الدراسة األصلية 2000 مصابة بالعدوى بفريوس العوز 
األمهات  من   44 مات  للوالدة  التاليتني  السنتني  وخالل  البرشي.  املناعي 
)2.2%( و310 من الولدان )15.5%(، مع استبعاد الوالدات بأجنة متعددة، 
تراوحت  إْذ  شهراً،   18 الثدي  من  الرضاعة  لفرتة  الوسطي  املعدل  بلغ  وقد 
قيم الرشائح الربعية بني 9.0 و22.5 شهراً، فيام بلغ املعدل الوسطي لفرتة 
الربعية  الرشائح  قيم  وتراوحت  شهرين،  الثدي  من  الرضاعة  عىل  االقتصار 
شهراً،   12 املختلط  اإلرضاع  لفرتة  الوسطي  املعدل  وبلغ  أشهر،   3 و   2 بني 
وتراوحت قيم الرشائح الربعية بني 6 – 18 شهراً. ومل يكن هناك ترابط ذو 
أهمية بني معدالت الوفيات أو معدالت الوفيات لدى األمهات بعد تصحيح 
الحمل الفريويس لدى األمهات وتصحيح العوامل األخرى. وقد ترافق اإلرضاع 
ع واألطفال، فيام بلغت النسبة  من الثدي بنقص معدالت الوفيات لدى الرُّضَّ
املصححة للمخاطر ملجمل عملية اإلرضاع من الثدي 0.44 بفاصلة ثقة %95 ، 
إْذ تراوحت النسبة املصححة للمخاطر بني 0.22 و0.72. وقد شوهدت هذه 
ع املصابني بالعدوى بفريوس العوز املناعي  التأثريات الواقية لدى كلٍّ من الرُّضَّ
ع غري املصابني بها. البرشي والرُّضَّ
االستنتاج: مل يرتافق اإلرضاع من الثدي لدى أمهات مصابات بالعدوى بفريوس 
بانخفاض ملحوظ يف  أو وفيات، بل  البرشي مبعدالت مراضة  املناعي  العوز 
الوفيات لدى أطفالهن.
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